Yingwen Wu

Helmholtz Institute for Pharmaceutical Research Saarland — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

3h-index76citations6works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

DNA Repair Mechanisms(2), Cancer-related Molecular Pathways(2), RNA Research and Splicing(2), RNA modifications and cancer(2), Bacterial Genetics and Biotechnology(1)

Publications6 total

Identification of a new protein-RNA interaction inhibitor targeting the KH34 region of the insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2/IMP2)
European Journal of Medicinal Chemistry·2026Open Access
Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality
Cell Genomics·2025· 3 citedOpen Access
Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality
2024Open Access
Establishment of an In Bacterio Assay for the Assessment of Carbon Storage Regulator A (CsrA) Inhibitors
ChemBioChem·2023Open Access
Phage display-based discovery of cyclic peptides against the broad spectrum bacterial anti-virulence target CsrA
European Journal of Medicinal Chemistry·2022· 5 citedOpen Access
First Small-Molecule Inhibitors Targeting the RNA-Binding Protein IGF2BP2/IMP2 for Cancer Therapy
ACS Chemical Biology·2022· 68 cited

Frequent Co-authors

Ben G. E. Zoller(5), Martin Empting(5), Alexandra K. Kiemer(4), Simon Both(3), Chelsea E. Cunningham(2), Frederick S. Vizeacoumar(2), Yue Zhang(2), Liliia Kyrylenko(2), Vincent Maranda(2), Jared D.W. Price(2), Peng Gao(2), Konrad Wagner(2), Mary Lazell-Wright(2), Ashtalakshmi Ganapathysamy(2), Rithik Hari(2), Kalpana K. Bhanumathy(2), Connor Denomy(2), Alain Morejon Morales(2), Faizaan Khan(2), Shayla R. Mosley(2)